ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 55 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,465,000 | -32.6% | 190,000 | 0.0% | 0.10% | -28.6% |
| Q3 2016 | $2,172,000 | -7.1% | 190,000 | 0.0% | 0.13% | -7.0% |
| Q2 2016 | $2,339,000 | +21.8% | 190,000 | 0.0% | 0.14% | +33.6% |
| Q1 2016 | $1,921,000 | -55.1% | 190,000 | 0.0% | 0.11% | -50.0% |
| Q4 2015 | $4,283,000 | +75.7% | 190,000 | +29.3% | 0.21% | +50.7% |
| Q3 2015 | $2,437,000 | +27.3% | 146,900 | +72.6% | 0.14% | +36.5% |
| Q2 2015 | $1,915,000 | -12.7% | 85,100 | 0.0% | 0.10% | -37.0% |
| Q1 2015 | $2,194,000 | +90.9% | 85,100 | +61.2% | 0.16% | +32.0% |
| Q4 2014 | $1,149,000 | +14.9% | 52,800 | 0.0% | 0.12% | -10.7% |
| Q3 2014 | $1,000,000 | -18.7% | 52,800 | 0.0% | 0.14% | -16.2% |
| Q2 2014 | $1,230,000 | -30.8% | 52,800 | 0.0% | 0.17% | -39.5% |
| Q1 2014 | $1,777,000 | +167.6% | 52,800 | +134.7% | 0.28% | +34.6% |
| Q4 2013 | $664,000 | – | 22,500 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 1,839,730 | $41,468,000 | 7.46% |
| BVF INC/IL | 991,433 | $22,347,000 | 3.81% |
| Iguana Healthcare Management, LLC | 400,000 | $9,016,000 | 2.97% |
| APEX CAPITAL, LLC | 382,000 | $8,610,000 | 0.92% |
| Birchview Capital, LP | 58,689 | $1,323,000 | 0.76% |
| BRAVE ASSET MANAGEMENT INC | 46,550 | $1,049,000 | 0.71% |
| HAMILTON LANE ADVISORS LLC | 44,376 | $1,000,000 | 0.44% |
| NJ State Employees Deferred Compensation Plan | 70,000 | $1,578,000 | 0.32% |
| Eventide Asset Management | 190,000 | $4,283,000 | 0.21% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 308,600 | $6,956,000 | 0.18% |